Cytek Biosciences to Participate in Notable Investor Conferences
Cytek Biosciences, Inc. (Nasdaq: CTKB), renowned for its innovative cell analysis solutions, is gearing up for a series of significant investor conferences. These events are crucial opportunities for the company to connect with investors and showcase its advancements in cell analysis technology.
Upcoming Conference Participation
Cytek will attend the following key conferences to engage with the investment community:
- UBS Global Healthcare Conference
Cytek will participate in investor one-on-one meetings on a specific date in November, providing insights into the company’s strategic vision and growth prospects. - Stephens NASH25 Investment Conference
A fireside chat will occur on an upcoming date in November at which company leaders will discuss developments and address investor queries. - Piper Sandler 37th Annual Healthcare Conference
On another date in December, Cytek will hold a fireside chat where representatives will elaborate on the company’s innovations and market position.
Investors and interested parties will have the chance to access live and archived presentations from these conferences on the Cytek Biosciences website, ensuring that everyone can stay informed about the latest updates and announcements.
About Cytek Biosciences
Cytek Biosciences (Nasdaq: CTKB) is at the forefront of advancing cell analysis technologies. The company is committed to innovation through its patented Full Spectrum Profiling™ (FSP) technology, which enhances the precision and sensitivity of cell analysis.
Utilizing full-spectrum fluorescent signals, Cytek’s technology allows for a more comprehensive understanding of cells, supporting researchers in their efforts across various scientific domains. The company’s flagship products include the Cytek Aurora™, Northern Lights™, and the Cytek Orion™ reagent systems, which cater to a wide array of research needs.
Global Reach and Product Offering
Headquartered in Fremont, California, Cytek operates with offices and distribution channels worldwide, demonstrating its global presence in the biotech field. Their product portfolio not only encompasses innovative flow cytometers and imaging systems but also includes a variety of reagents, software, and services designed to provide comprehensive solutions for researchers.
Through relentless innovation and a commitment to customer satisfaction, Cytek Biosciences continues to establish itself as a crucial player in the cell analysis landscape.
Commitment to Transparency
Cytek believes in maintaining an open line of communication with investors and stakeholders. In addition to participation in prominent investor conferences, the company utilizes its website, social media platforms, and official communications to disseminate important information about its business operations, financial performance, and market developments. Cytek encourages investors to regularly check these channels for the latest news and updates.
Media and Investor Relations
For further inquiries, media representatives can contact:
Media Contact:
Stephanie Olsen
Lages & Associates
(949) 453-8080
Email: stephanie@lages.com
For investor relations, reach out to:
Investor Contact:
Paul Goodson
Head of Investor Relations
Cytek Biosciences
Email: pgoodson@cytekbio.com
Frequently Asked Questions
What is Cytek Biosciences known for?
Cytek Biosciences is recognized for its innovative cell analysis solutions, especially its Full Spectrum Profiling™ technology.
Where will Cytek participate in investor conferences?
Cytek will participate in several key conferences, including the UBS Global Healthcare Conference and the Piper Sandler Annual Healthcare Conference.
What are Cytek's core products?
Cytek's core products include the Cytek Aurora™, Northern Lights™, and Cytek Orion™ systems, designed for advanced cell analysis.
How can investors stay informed about Cytek?
Investors can stay updated through Cytek's website, social media channels, and by following its press releases and public announcements.
Who can be contacted for media inquiries?
Media inquiries can be directed to Stephanie Olsen at Lages & Associates for further assistance.